Turning Point Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Turning Point Therapeutics, Inc. has filed 302 SEC EDGAR filings since 06 Jan 2014

SEC filing history

Showing 126-150 of 302 matching filings.

Per page
25
Current page
6
SC 13G/A File 005-90986

SCHEDULE 13G/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90986

SC 13G/A filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90986

SC 13G/A filing

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
08 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
01 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90986

AMENDMENT TO FORM SC 13D

Filing date
06 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
27 Oct 2020
Reporting date
26 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238300

424B5

Filing date
27 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

FORM 8-K

Filing date
26 Oct 2020
Reporting date
26 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238300

424B5

Filing date
26 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
26 Oct 2020
Reporting date
24 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

FORM 8-K

Filing date
19 Aug 2020
Reporting date
19 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

FORM 8-K

Filing date
10 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-238300

424B5

Filing date
10 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38871

8-K

Filing date
10 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jul 2020
Reporting date
13 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .